The ORATOR trial found no significant difference in survival outcomes between radiation therapy and transoral robotic surgery for HPV-related oropharyngeal cancer. Radiation therapy patients ...
Compared with standard concurrent chemoradiation, neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to superior distant metastasis-free and overall ...
A pioneering study at King's College London, University of Oxford and Guy's and St Thomas' NHS Foundation Trust has successfully tested a new robotic surgical system for treating head and neck ...
Phase II trial assessing safety, efficacy and immune correlates of heterologous prime-boost with pBI-11 (IM) and TA-HPV (IM) plus pembrolizumab for advanced, PD-L1 CPS≥1, hrHPV+ oropharyngeal cancer.
A multidisciplinary panel of head and neck cancer specialists was recently assembled by ASCO to develop guideline recommendations for the role of transoral robotic surgery (TORS) in the management of ...
PARIS & BOSTON--(BUSINESS WIRE)-- Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy ...
A trial including 162 patients showed that surgeon-performed transoral/transcervical ultrasonography (USG) achieved a diagnostic accuracy of 86%, outperforming clinical examination and MRI (68% and 76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results